≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Routine general health check-up of defined subpopulation

DOID Endpoint Browser

Z21_ROUTI_GENERAL_HEALTH_CHECK_DEFIN_SUBPO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z10
  • Cause of death: ICD-10 — Z10

2 out of 7 registries used, show all original rules.

917

4. Check minimum number of events

None

917

5. Include endpoints

None

917

6. Filter based on genotype QC (FinnGen only)

917

Control definitions (FinnGen only)

Control exclude
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[0-1]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 917 775 142
Unadjusted period prevalence (%) 0.23 0.26 0.06
Median age at first event (years) 35.75 37.09 28.48

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
818
Matched controls
8179
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z10.8
ICD-10 Finland
Routine general health check-up of other defined subpopulations
213.8
323.0
656
151
Z00.0
ICD-10 Finland
General medical examination
16.4
193.9
342
342
RD211
NOMESCO Finland
NA
43.7
191.2
238
76
Z3231
NOMESCO Finland
Registered nurse
7.3
133.7
408
978
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
24.3
129.2
188
99
Z71.8
ICD-10 Finland
Other specified counselling
6.7
124.8
410
1063
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
+∞
107.7
101
*
LGA21
NOMESCO Finland
Laparoscopic sterilisation by constriction of Fallopian tubes
9.4
106.1
242
349
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
63.5
99.4
115
21
Z30.2
ICD-10 Finland
Sterilization
6.4
92.2
283
620
HMAK
NOMESCO Finland
NA
6.2
84.6
265
587
SPAT1252
SPAT
Overall medication plan or its review
17.8
75.5
121
79
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
13.1
69.0
126
112
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
+∞
66.6
63
*
SPAT1216
SPAT
Assessment of functional ability
7.4
64.7
167
274
Z01.0
ICD-10 Finland
Examination of eyes and vision
17.1
64.2
104
69
Z01.8
ICD-10 Finland
Other specified special examinations
9.3
64.1
141
179
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
5.4
55.6
186
421
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
54.7
51.6
61
12
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
8.6
51.4
117
155
SPAT1359
SPAT
Use of symptom diary
23.4
49.3
71
33
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
8.2
47.3
111
154
Z51.2
ICD-10 Finland
Other chemotherapy
484.1
46.8
46
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
104.1
45.3
49
5
Z01.1
ICD-10 Finland
Examination of ears and hearing
10.5
41.9
84
88
WZC30
NOMESCO Finland
Teaching
4.6
39.8
151
382
Z3229
NOMESCO Finland
Other healthcare associate professional
6.5
38.2
104
178
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
136.3
37.0
39
*
PLAK1
NOMESCO Finland
NA
46.3
36.3
44
10
SPAT1131
SPAT
Colonoscopy
11.9
35.3
66
60
RF410
NOMESCO Finland
NA
41.2
34.7
43
11
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.8
34.3
294
1381
-1
NOMESCO Finland
NA
2.6
34.2
356
1869
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
125.3
34.0
36
*
LCH11
NOMESCO Finland
Pharmacologic abortion
6.6
33.9
91
152
LCD10
NOMESCO Finland
Vaginal hysterectomy
7.6
33.9
82
118
R83
ICPC
Respiratory infection other
2.7
33.8
316
1561
RF420
NOMESCO Finland
NA
34.8
33.4
43
13
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
329.2
32.1
32
*
S15
ICPC
Foreign body in skin
6.3
31.3
87
152
PLAK0
NOMESCO Finland
NA
30.7
31.0
41
14
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
10.1
30.6
62
66
S18
ICPC
Laceration/cut
2.5
30.6
310
1580
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
59.0
29.3
34
6
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
6.4
28.7
78
132
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.0
27.2
50
44
ZX120
NOMESCO Finland
Intravenous
5.0
27.2
92
203
KHV
NOMESCO Finland
NA
77.9
26.9
30
*
LAF20
NOMESCO Finland
Unilateral transvaginal salpingo-oophorectomy
74.9
25.9
29
*
Z51.0
ICD-10 Finland
Radiotherapy session
25.0
25.9
36
15
SPAT1360
SPAT
Extensive global examination
5.5
25.7
79
156
SPAT1310
SPAT
Counselling related to known health issue
2.4
25.5
266
1349
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.7
25.4
210
937
R1250
NOMESCO Finland
Evaluation of functional capability
15.9
25.3
41
27
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
8.4
24.3
54
68
Z30.0
ICD-10 Finland
General counselling and advice on contraception
4.0
24.3
104
289
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
23.7
205
935
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
23.6
292
1597
XQ800
NOMESCO Finland
Prick test
5.1
23.0
75
159
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
22.8
94
252
PLAK2
NOMESCO Finland
NA
41.4
22.8
28
7
R51.80
ICD-10 Finland
Headache
3.1
22.5
139
513
SPAT1249
SPAT
Treatment-related counselling outside office
2.2
22.3
325
1906
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.4
21.3
80
196
R01AD01
ATC
beclometasone; nasal
2.7
21.2
162
681
ZYC01
NOMESCO Finland
Remote contact by phone
6.4
20.6
55
91
XG474
NOMESCO Finland
Exhalation nntrogen oxide
9.6
20.5
42
46
Z2445
NOMESCO Finland
Psychologist
5.8
20.3
59
109
N81.6
ICD-10 Finland
Rectocele
4.7
20.0
70
160
SPAT1153
SPAT
Removal of sutures
2.3
19.9
217
1103
M54.5
ICD-10 Finland
Low back pain
2.2
19.9
265
1478
N03AX12
ATC
gabapentin; oral
3.1
19.8
120
434
J45.8
ICD-10 Finland
Mixed asthma
9.3
19.8
41
46
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
19.8
146
601
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
15.1
19.5
32
22
J45.9
ICD-10 Finland
Asthma, unspecified
2.9
19.4
133
521
Z72.2
ICD-10 Finland
Drug use
47.2
19.3
23
5
AN2
HP
Balloon angioplasty, including several vessels
11.7
19.1
35
31
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.0
19.0
467
3310
N05AH04
ATC
quetiapine; oral
2.7
18.9
144
603
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
19.3
18.7
28
15
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
7.6
18.7
44
61
XA800
NOMESCO Finland
Neuropsychological investigation
6.3
18.6
50
84
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
4.9
18.5
61
131
SAA01
NOMESCO Finland
Simple examination of mouth
2.0
18.3
604
4757
XA402
NOMESCO Finland
ENMG
19.9
18.3
27
14
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
18.0
139
585
N05BA04
ATC
oxazepam; oral
2.3
17.9
192
961
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
2.7
17.9
135
561
U02
ICPC
Urinary frequency/urgency
3.0
17.8
111
410
R21
ICPC
Throat symptom/complaint
2.2
17.8
215
1140
TUPEI
NOMESCO Finland
NA
4.6
17.7
62
142
N81.1
ICD-10 Finland
Cystocele
4.4
17.4
64
154
DFF15
NOMESCO Finland
Speech audiometry
14.3
17.4
29
21
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
3.5
17.0
82
251
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
22.4
16.9
24
11
R50.9
ICD-10 Finland
Fever, unspecified
2.9
16.9
109
410
D19
ICPC
Teeth/gum symptom/complaint
2.1
16.9
242
1373
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.5
16.5
143
640
H02AB09
ATC
hydrocortisone; systemic
11.5
16.3
30
27
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.1
16.3
52
108
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
19.0
16.1
24
13
R05
ICPC
Cough
2.2
16.0
180
916
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.1
16.0
203
1092
N06AX11
ATC
mirtazapine; oral
2.0
16.0
242
1399
R03BA01
ATC
beclometasone; inhalant
2.6
16.0
126
534
XX1AD
NOMESCO Finland
Other CT-examination
26.9
15.6
21
8
N02BE01
ATC
paracetamol; systemic, rectal
2.0
15.6
646
5333
KMAK
NOMESCO Finland
NA
1.8
15.6
455
3326
A03
ICPC
Fever
2.3
15.3
155
750
M79.6
ICD-10 Finland
Pain in limb
2.0
15.2
263
1595
ZY010
NOMESCO Finland
Hospital outpatient
4.4
15.2
55
131
J01EA01
ATC
trimethoprim; systemic
2.1
15.1
206
1140
N02AA05
ATC
oxycodone; systemic
3.4
15.1
76
241
U01
ICPC
Dysuria/painful urination
3.3
15.0
77
248
N02AX02
ATC
tramadol; systemic, rectal
1.9
14.8
257
1560
R06.0
ICD-10 Finland
Dyspnoea
2.4
14.8
144
681
RF120
NOMESCO Finland
NA
18.8
14.7
22
12
SPAT1097
SPAT
Recording of ECG
3.0
14.6
87
310
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
14.5
79
265
L01
ICPC
Neck symptom/complaint
2.6
14.3
113
478
RF210
NOMESCO Finland
NA
5.8
14.2
40
72
F92.0
ICD-10 Finland
Depressive conduct disorder
43.3
14.1
17
*
A23
ICPC
Risk factor NOS
2.8
14.0
94
363
R03AC02
ATC
salbutamol; inhalant
1.8
14.0
403
2892
MBA96
NOMESCO Finland
Other removal of retained products of conception after delivery or abortion
5.8
13.9
39
70
Z2446
NOMESCO Finland
Social worker
3.7
13.7
61
175
R07
ICPC
Sneezing/nasal congestion
3.0
13.7
82
292
SPAT1254
SPAT
Administration of medicine
2.7
13.6
95
375
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
13.6
13
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
13.6
110
474
G43.9
ICD-10 Finland
Migraine, unspecified
3.4
13.5
67
210
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
18.6
13.4
20
11
XQ848
NOMESCO Finland
Dermatological photography
8.3
13.4
29
36
TQW80
NOMESCO Finland
Local dermatologic skincare
7.4
13.3
31
43
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.8
13.1
89
346
SPAT1106
SPAT
Acupuncture
17.1
13.0
20
12
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.3
13.0
48
117
N06AB04
ATC
citalopram; systemic
2.1
12.8
162
862
EBA00
NOMESCO Finland
Extraction of tooth
1.8
12.7
263
1682
SPAT1283
SPAT
Restricted health certificate
1.9
12.7
205
1199
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
24.7
12.5
17
7
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
131.9
12.5
13
*
C07AB07
ATC
bisoprolol; oral
1.9
12.4
230
1412
SPAT1324
SPAT
Screening procedure
1.9
12.4
233
1439
SPAT1098
SPAT
Exercise ECG
8.6
12.3
26
31
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
12.3
86
338
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.9
12.2
50
134
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
38.2
12.2
15
*
EMAK
NOMESCO Finland
NA
4.4
12.2
44
105
Z00.8
ICD-10 Finland
Other general examinations
4.2
12.2
46
115
ZXD35
NOMESCO Finland
Usual procedure
5.2
12.1
37
74
F51.0
ICD-10 Finland
Nonorganic insomnia
2.3
12.1
125
606
N06AX21
ATC
duloxetine; oral
2.7
12.0
86
346
A02BC02
ATC
pantoprazole; systemic
1.7
12.0
429
3229
Z3232
NOMESCO Finland
Midwife
2.4
11.9
103
458
H02AB06
ATC
prednisolone; systemic
1.8
11.9
297
2006
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
11.8
146
766
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
9.1
11.8
24
27
M25.5
ICD-10 Finland
Pain in joint
1.9
11.8
219
1345
J02AC01
ATC
fluconazole; systemic
1.7
11.7
357
2555
G44.2
ICD-10 Finland
Tension-type headache
2.3
11.7
111
516
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
11.6
323
2249
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
7.3
11.6
27
38
G54.0
ICD-10 Finland
Brachial plexus disorders
5.6
11.6
33
61
P01AB01
ATC
metronidazole; oral, rectal
1.7
11.6
306
2099
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.2
11.6
132
668
Z10.3
ICD-10 Finland
Routine general health check-up of sports teams
+∞
11.5
11
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
7.1
11.4
27
39
A41.9
ICD-10 Finland
Sepsis, unspecified
7.4
11.3
26
36
R5599
NOMESCO Finland
Other rehabilitation service
6.4
11.3
29
47
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
7.8
11.2
25
33
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.3
11.2
41
100
T74.1
ICD-10 Finland
Physical abuse
6.5
11.2
28
44
C07AA05
ATC
propranolol; systemic
2.0
11.1
154
844
Y96.9
ICD-10 Finland
Unspecified type of accident
9.4
11.0
22
24
JONO
NOMESCO Finland
NA
10.2
11.0
21
21
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.8
11.0
46
126
M01AC06
ATC
meloxicam; systemic, rectal
1.7
11.0
260
1720
SPAT1301
SPAT
No procedures
1.9
10.9
198
1200
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.6
10.9
79
319
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
12.1
10.9
19
16
SDA02
NOMESCO Finland
Parodonthologic therapy
1.7
10.9
271
1821
F43.00
ICD-10 Finland
Acute stress reaction mild
4.8
10.8
35
75
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.0
10.8
22
25
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.8
10.8
70
263
R53
ICD-10 Finland
Malaise and fatigue
2.1
10.7
130
677
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.6
10.7
36
81
R01AC01
ATC
cromoglicic acid; nasal
3.2
10.7
55
179
N30.0
ICD-10 Finland
Acute cystitis
2.3
10.6
106
505
R11
ICD-10 Finland
Nausea and vomiting
3.1
10.6
58
197
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
5.2
10.6
32
64
RS221
NOMESCO Finland
NA
9.3
10.5
21
23
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
10.5
472
3721
N06AX16
ATC
venlafaxine; oral
2.2
10.5
110
537
RK112
NOMESCO Finland
NA
111.4
10.4
11
*
Z62.2
ICD-10 Finland
Institutional upbringing
+∞
10.4
10
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
10.4
79
327
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
33.0
10.3
13
*
XW000
NOMESCO Finland
Bone marrow biopsy
5.9
10.3
28
49
SPAT1059
SPAT
Spirometry at the office
3.9
10.3
42
113
K02.1
ICD-10 Finland
Caries of dentine
1.6
10.3
464
3650
N06AB10
ATC
escitalopram; oral
1.9
10.3
167
969
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
10.3
387
2906
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
10.3
148
824
T51.0
ICD-10 Finland
Toxic effect: Ethanol
23.7
10.3
14
6
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
10.2
65
244
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
4.6
10.2
34
76
M03BX02
ATC
tizanidine; oral
1.6
10.1
480
3822
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.6
10.1
45
131
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
10.0
141
778
L03
ICPC
Low back symptom/complaint
1.9
10.0
170
1006
K05
ICPC
Irregular heartbeat other
5.8
9.9
27
48
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.6
9.9
43
123
LEF00
NOMESCO Finland
Anterior colporraphy with sutures for primary cystocele
4.9
9.9
31
65
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
9.8
385
2909
K56.1
ICD-10 Finland
Intussusception
26.4
9.8
13
5
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.0
9.8
38
98
R5120
NOMESCO Finland
Preparation of an aid
8.9
9.8
20
23
O04.1
ICD-10 Finland
Medical abortion, incomplete, complicated by delayed or excessive haemorrhage
10.8
9.8
18
17
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
9.7
111
561
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
2.2
9.7
100
483
WX308
NOMESCO Finland
Sacral anesthesy
55.7
9.7
11
*
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.4
9.7
83
368
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
2.2
9.6
104
513
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.5
9.6
33
76
Z97.4
ICD-10 Finland
Presence of external hearing-aid
10.2
9.5
18
18
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.9
9.5
30
63
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
101.1
9.4
10
*
TLOPK
NOMESCO Finland
NA
101.1
9.4
10
*
N01
ICPC
Headache
2.2
9.4
94
448
Z10.2
ICD-10 Finland
Routine general health check-up of armed forces
30.4
9.4
12
*
N03AX16
ATC
pregabalin; oral
2.0
9.4
134
739
Z3226
NOMESCO Finland
Physiotherapist
2.0
9.4
123
658
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
9.4
103
513
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.7
9.4
63
244
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
22.0
9.4
13
6
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
22.0
9.4
13
6
B18.2
ICD-10 Finland
Chronic viral hepatitis C
9.7
9.3
18
19
SPAT1240
SPAT
Therapeutic discussion
2.2
9.3
100
494
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
3.4
9.2
44
136
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
9.2
293
2086
ZX080
NOMESCO Finland
Image guided radiotherapy
5.0
9.2
28
57
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
9.2
171
1039
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.5
9.1
31
71
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
9.1
330
2430
D11
ICPC
Diarrhoea
2.2
9.1
96
469
F93.89
ICD-10 Finland
Other childhood emotional disorders
15.8
9.1
14
9
R02
ICPC
Shortness of breath/dyspnoea
2.5
8.9
70
296
PLAK3
NOMESCO Finland
NA
24.3
8.9
12
5
RD210
NOMESCO Finland
NA
6.9
8.9
21
31
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.1
8.9
107
552
Z29
ICPC
Social problem NOS
8.7
8.8
18
21
WX290
NOMESCO Finland
Other blockade of nerve
1.6
8.8
379
2903
N05BA01
ATC
diazepam; systemic, rectal
2.3
8.7
84
392
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
14.2
8.7
14
10
RJ630
NOMESCO Finland
NA
50.5
8.7
10
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
8.7
55
206
N05CF01
ATC
zopiclone; oral
1.7
8.7
187
1191
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.0
8.6
119
651
M79.7
ICD-10 Finland
Fibromyalgia
4.3
8.6
30
71
Z10
ICD-10 Finland
Routine general health check-up of defined subpopulation
16.5
8.6
13
8
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
16.5
8.6
13
8
RF220
NOMESCO Finland
NA
9.1
8.6
17
19
LCA06
NOMESCO Finland
Biopsy of endometrium
2.0
8.5
118
646
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.1
8.4
104
541
M54.2
ICD-10 Finland
Cervicalgia
2.8
8.4
54
204
R03AK08
ATC
formoterol and beclometasone; inhalant
4.1
8.4
31
77
RS110
NOMESCO Finland
NA
90.9
8.4
9
*
N63
ICD-10 Finland
Unspecified lump in breast
2.6
8.4
61
248
N06AB05
ATC
paroxetine; oral
2.8
8.4
53
198
ZXC00
NOMESCO Finland
Use of diathermy
12.9
8.4
14
11
H13
ICPC
Plugged feeling ear
2.1
8.4
92
459
XQ802
NOMESCO Finland
Epicutan test
5.1
8.4
25
50
WZA90
NOMESCO Finland
Other doctors statement
1.7
8.4
177
1119
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
2.1
8.3
91
451
S06.0
ICD-10 Finland
Concussion
2.4
8.3
67
288
A98
ICPC
Health maint/preventive medicine
3.9
8.3
805
7691
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
8.3
111
599
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.3
8.3
77
356
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
8.2
142
842
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
8.1
33
90
H01
ICPC
Ear pain/earache
2.2
8.1
83
401
Z06
ICPC
Unemployment problem
8.2
8.1
17
21
6341A
ICD-9 Finland
NA
8.2
8.1
17
21
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
8.1
51
190
ITSEH
NOMESCO Finland
NA
11.8
8.1
14
12
RS314
NOMESCO Finland
NA
33.7
8.1
10
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
17.4
8.1
12
7
Z11
ICPC
Compliance/being ill problem
17.4
8.1
12
7
R96
ICPC
Asthma
2.6
8.1
59
241
D10
ICPC
Vomiting
2.5
8.1
61
252
DFF00
NOMESCO Finland
Pure tone audiometry
3.4
8.0
37
112
WYA30
SPAT
NA
22.3
8.0
11
5
R5140
NOMESCO Finland
Monitoring the use of the aid
2.6
8.0
58
235
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.9
8.0
46
162
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
8.0
41
135
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.0
7.9
24
49
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
6.2
7.9
20
33
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.6
7.9
55
220
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
7.8
58
239
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
4.0
7.8
30
78
K08.80
ICD-10 Finland
Toothache NOS
2.3
7.8
74
346
N06BA04
ATC
methylphenidate; oral
4.7
7.7
25
55
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.6
7.7
21
38
J01CA08
ATC
pivmecillinam; oral
1.5
7.7
348
2670
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
7.7
216
1478
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
8.1
7.6
16
20
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.1
7.6
16
20
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
18.6
7.6
11
6
D82
ICPC
Teeth/gum disease
0.6
7.6
148
2191
XKD00
NOMESCO Finland
Uroflowmetry
3.0
7.6
41
140
N39.3
ICD-10 Finland
Stress incontinence
2.6
7.6
55
222
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
25.3
7.6
10
*
XKX00
NOMESCO Finland
Pelvic floor electromyography
25.3
7.6
10
*
ZX121
NOMESCO Finland
Central venous catheter
25.3
7.6
10
*
M54.6
ICD-10 Finland
Pain in thoracic spine
2.6
7.5
53
213
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
7.5
105
576
J01DB01
ATC
cefalexin; oral
1.6
7.5
614
5370
RS130
NOMESCO Finland
NA
80.8
7.4
8
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
80.8
7.4
8
*
SPAT1260
SPAT
Consultation of another employee
1.9
7.4
108
600
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.4
7.4
21
40
N06AA09
ATC
amitriptyline; systemic
2.6
7.4
54
219
N83.1
ICD-10 Finland
Corpus luteum cyst
5.7
7.4
20
36
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.5
7.4
33
98
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
0.6
7.4
109
1730
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.5
7.3
57
240
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.4
7.3
60
260
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
7.3
86
440
K10.3
ICD-10 Finland
Alveolitis of jaws
3.0
7.3
40
138
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.2
7.3
21
41
A44
ICPC
General and Unspecified, Preventive immunization/medic
2.4
7.2
59
254
Y96.8
ICD-10 Finland
Other type of accident
15.9
7.2
11
7
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
15.9
7.2
11
7
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.4
7.2
16
22
R52.2
ICD-10 Finland
Other chronic pain
4.5
7.2
24
55
R4190
NOMESCO Finland
Nutritional therapy
3.5
7.2
32
95
XKC03
NOMESCO Finland
Water cystometry
4.9
7.2
22
46
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
2.9
7.1
41
145
LEG13
NOMESCO Finland
Vaginal transobturatorial urethropexy
8.0
7.1
15
19
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
7.1
111
632
TAB00
NOMESCO Finland
Lumbar puncture
3.1
7.1
36
118
K03.9
ICD-10 Finland
Disease of hard tissues of teeth, unspecified
12.2
7.1
12
10
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
7.1
62
280
SPAT1263
SPAT
Sampling
1.5
6.9
276
2047
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
6.9
521
4421
R03BA08
ATC
ciclesonide; inhalant
2.4
6.8
57
250
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
11.0
6.8
12
11
TJK01
NOMESCO Finland
Laparoscopic cholangiography
9.4
6.8
13
14
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.4
6.8
23
54
Z09
ICPC
Legal problem
40.4
6.8
8
*
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
40.4
6.8
8
*
RF212
NOMESCO Finland
NA
40.4
6.8
8
*
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
40.4
6.8
8
*
SPAT1081
SPAT
Cardiorespiratory global assessment
3.5
6.8
29
84
RS120
NOMESCO Finland
NA
22.7
6.7
9
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
22.7
6.7
9
*
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
22.7
6.7
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
22.7
6.7
9
*
R33
ICD-10 Finland
Retention of urine
4.3
6.7
23
55
K08.3
ICD-10 Finland
Retained dental root
2.9
6.6
38
134
RS222
NOMESCO Finland
NA
7.9
6.6
14
18
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.8
6.6
26
70
N07BB01
ATC
disulfiram; oral
3.1
6.6
33
108
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.8
6.5
40
149
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
6.5
47
193
C10AA01
ATC
simvastatin; oral
1.7
6.5
146
934
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
70.4
6.4
7
*
RF110
NOMESCO Finland
NA
70.4
6.4
7
*
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
70.4
6.4
7
*
OMAH0
NOMESCO Finland
NA
70.4
6.4
7
*
RP210
NOMESCO Finland
NA
70.4
6.4
7
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.0
6.4
24
62
JGC01
NOMESCO Finland
Laparoscopic rectopexy
14.4
6.4
10
7
S10
ICPC
Boil/carbuncle
2.9
6.4
37
132
R74
ICPC
Upper respiratory infection acute
1.5
6.4
243
1778
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
1.9
6.4
93
520
SPAT1058
SPAT
PEF monitoring instruction
2.4
6.4
49
208
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
6.3
56
252
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
9.3
6.3
12
13
N06AX22
ATC
agomelatine; oral
4.4
6.3
21
49
N03AE01
ATC
clonazepam; systemic
3.0
6.3
34
118
RF122
NOMESCO Finland
NA
+∞
6.3
6
*
ZX131
NOMESCO Finland
Intrathecal
+∞
6.3
6
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
6.3
6
*
F91.2
ICD-10 Finland
Socialized conduct disorder
+∞
6.3
6
*
R07.3
ICD-10 Finland
Other chest pain
2.4
6.3
50
214
Z08
ICPC
Social welfare problem
7.1
6.2
14
20
A06AD11
ATC
lactulose; oral
2.2
6.2
61
292
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
5.8
6.2
16
28
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
6.2
47
198
C08CA13
ATC
lercanidipine; oral
2.3
6.2
55
250
M79.1
ICD-10 Finland
Myalgia
2.0
6.1
81
435
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
6.1
400
3264
H03AA01
ATC
levothyroxine sodium; systemic
1.6
6.1
157
1041
N05BA12
ATC
alprazolam; oral
2.1
6.1
65
323
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.9
6.0
35
126

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021589) Normoblasts [#/volume] in Blood
629
2947
4.61
106.23
8.6
7.6
e9/l
0.0
0.0
1.11
582
2317
(3002179) Metamyelocytes/100 leukocytes in Blood
167
378
5.18
71.06
5.1
3.8
%
0.4
0.5
0.39
20
76
(3025159) Blasts/100 leukocytes in Blood
166
377
5.16
70.33
5.2
4.2
%
0.0
1.0
0.51
19
82
(3021440) Promyelocytes/100 leukocytes in Blood
167
388
5.04
68.81
5.2
4.2
%
0.0
0.1
2.16
20
93
(3017181) Myelocytes/100 leukocytes in Blood
166
402
4.82
64.89
5.2
4.1
%
0.6
0.9
0.47
20
101
(3009214) Lutropin [Units/volume] in Serum or Plasma
87
207
4.54
34.08
2.1
1.3
u/l
8.4
10.8
0.82
67
176
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
804
6620
2.74
23.27
10.5
7.8
ml/min/173m2
89.4
88.9
0.26
728
5315
(3002385) Erythrocyte distribution width [Ratio]
776
6469
2.30
18.64
14.5
10.4
%
13.5
13.5
0.03
767
6304
(3044242) Glucose [Moles/volume] in Arterial blood
16
10
16.27
18.54
1.5
11.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
307
1897
1.93
18.24
2.9
2.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
64
196
3.44
17.53
1.8
1.5
nmol/l
0.4
0.4
0.03
55
152
(3022096) Basophils/100 leukocytes in Blood
404
2767
1.82
17.08
7.0
4.9
%
0.7
0.7
0.48
396
2567
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
56
164
3.57
16.42
2.0
1.3
ug/l
2.5
4.5
1.67
44
153
(3006504) Eosinophils/100 leukocytes in Blood
408
2868
1.76
15.30
7.0
4.8
%
2.9
2.7
1.01
400
2656
(3044889) 12 lead EKG panel
575
4470
1.77
15.00
2.5
2.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
32
66
4.99
14.82
3.8
3.2
u/ml
21.8
55.5
0.83
32
66
(3019069) Monocytes/100 leukocytes in Blood
408
2895
1.74
14.60
7.1
5.0
%
8.5
8.2
1.20
399
2712
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
20
26
7.84
14.47
3.7
2.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
129
630
2.22
14.25
1.9
1.3
iu/l
24.4
33.6
2.19
107
547
(40760892) CBC W Ordered Manual Differential panel - Blood
260
1645
1.81
13.66
4.3
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
687
5704
1.82
13.47
3.8
3.8
pmol/l
14.6
14.4
1.15
666
5286
(3029937) Albumin [Presence] in Urine by Test strip
258
1645
1.79
13.13
3.1
2.9
estimate
0.0
0.0
1.34
197
588
(3006315) Basophils [#/volume] in Blood
417
3038
1.68
13.11
7.0
4.8
e9/l
0.0
0.0
0.29
384
2590
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
585
4666
1.70
12.96
6.9
5.9
u/l
75.0
76.1
0.36
573
4374
(3001604) Monocytes [#/volume] in Blood
416
3039
1.68
12.87
7.0
4.8
e9/l
0.5
0.5
0.02
385
2581
(3013650) Neutrophils [#/volume] in Blood by Automated count
476
3650
1.63
11.82
11.6
7.7
e9/l
3.6
3.9
3.58
443
3121
(3018010) Neutrophils/100 leukocytes in Blood
408
3012
1.64
11.80
7.0
4.6
%
54.2
56.0
2.88
401
2827
(3013115) Eosinophils [#/volume] in Blood
423
3160
1.63
11.60
8.5
4.9
e9/l
0.2
0.2
0.13
396
2753
(3009542) Hematocrit [Volume Fraction] of Blood
646
7352
0.59
11.25
14.2
8.9
%
40.8
40.2
3.31
583
6077
(3023103) Potassium [Moles/volume] in Serum or Plasma
798
7072
1.99
11.17
11.2
8.3
mmol/l
3.9
3.9
1.18
788
6862
(3002030) Lymphocytes/100 leukocytes in Blood
411
3073
1.61
11.07
7.1
4.7
%
31.2
29.9
1.71
402
2872
(3011288) Drugs identified in Urine by Screen method
57
215
2.76
10.96
6.2
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
36
103
3.60
10.96
4.8
2.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
794
7039
1.95
10.89
11.2
8.2
mmol/l
139.5
139.8
3.83
784
6840
(3017569) Oxygen content in Arterial blood
16
9
18.07
10.75
1.4
12.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
587
4807
1.61
10.61
4.0
3.1
mm/h
10.9
10.2
0.70
576
4481
(3017446) Testosterone [Moles/volume] in Serum or Plasma
59
231
2.66
10.56
2.4
1.7
nmol/l
12.3
12.0
0.11
54
207
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
170
1020
1.82
10.34
2.2
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
420
3200
1.58
10.18
7.0
4.7
e9/l
2.0
2.0
0.17
392
2805
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
188
1171
1.76
10.06
2.5
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
707
6103
1.69
9.99
3.5
3.8
mmol/mol
38.5
37.7
1.72
687
5756
(3013826) Glucose [Moles/volume] in Serum or Plasma
417
3195
1.56
9.71
3.6
3.2
mmol/l
6.3
6.3
0.31
402
2912
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
349
2572
1.58
9.62
2.3
2.0
nmol/l
76.7
75.2
0.49
340
2392
(3003338) MCHC [Mass/volume]
607
6942
0.63
9.49
15.6
10.0
g/l
332.9
332.3
0.89
590
6878
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
26
6.25
9.48
2.5
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
43
153
2.90
9.23
1.7
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
147
875
1.81
9.11
1.6
1.6
%
1.4
1.3
2.22
139
797
(3009508) Creatinine [Moles/volume] in Urine
210
1385
1.67
9.04
3.4
2.6
mmol/l
7.4
7.8
0.45
201
1196
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
177
1116
1.73
9.00
1.6
1.5
pmol/l
466.0
25314248.9
1.07
166
956
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
335
2494
1.54
8.60
2.9
2.7
—
—
—
0
0
(3013512) EKG study
65
1290
0.47
8.33
2.8
2.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
750
6684
1.67
8.17
4.4
4.2
mu/l
1.8
2.6
1.47
738
6265
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
248
1747
1.58
8.05
2.3
2.4
ng/l
16.3
39.4
2.67
143
829
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
319
2378
1.52
8.02
5.6
4.8
mmol/l
1.2
1.2
0.19
295
1922
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
34
115
3.03
8.00
2.2
5.3
%
1.9
1.7
0.31
34
109
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
368
2833
1.50
7.90
6.0
5.1
umol/l
9.1
10.7
1.97
358
2672
(40761511) CBC panel - Blood by Automated count
851
7890
2.09
7.90
9.0
7.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
34
116
3.01
7.88
2.2
5.3
%
0.6
1.0
7.97
34
110
(3022145) Colonoscopy Study observation
104
586
1.87
7.65
1.2
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
153
972
1.69
7.49
2.7
2.1
mosm/kgh2o
498.9
543.9
1.89
141
813
(3018405) Lactate [Moles/volume] in Arterial blood
32
110
2.98
7.34
3.5
4.5
mmol/l
1.3
1.4
0.27
32
110
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
845
7845
1.98
7.33
8.6
7.2
u/l
26.5
25.6
0.61
830
7622
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
10
5
20.20
7.14
9.9
10.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
62
307
2.09
6.60
1.8
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
21
5.78
6.60
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
156
1028
1.62
6.58
2.5
2.0
e6/l
9.2
8.8
0.08
147
888
(4198724)
13
25
5.26
6.50
3.8
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
168
1133
1.59
6.44
1.3
1.2
u/ml
7.8
11.6
0.53
116
505
(3035350) Ketones [Presence] in Urine by Test strip
390
3129
1.43
6.37
2.9
2.7
estimate
0.0
0.0
0.50
204
576
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
745
6767
1.54
6.00
3.2
3.2
mmol/l
5.6
5.6
0.28
726
6306
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
171
1183
1.55
5.84
1.3
1.2
iu/ml
21.1
27.4
0.69
46
406
(3021601) Nitrite [Presence] in Urine by Test strip
390
3164
1.40
5.83
3.7
3.8
estimate
0.0
0.0
0.50
199
591
(3014576) Chloride [Moles/volume] in Serum or Plasma
81
462
1.83
5.75
3.8
6.0
mmol/l
104.2
104.4
0.16
81
452
(40761995) Spermatozoa Progressive [#/volume] in Semen
13
28
4.70
5.75
3.1
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
13
28
4.70
5.75
6.2
5.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
392
3195
1.40
5.65
2.9
2.8
estimate
0.0
0.0
0.80
200
586
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
330
0.27
5.54
1.6
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
98
598
1.72
5.54
1.7
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
170
1189
1.53
5.50
2.5
2.7
mg/l
47.3
218.0
1.03
138
684
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
369
2987
1.39
5.50
3.3
3.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
178
1259
1.51
5.47
1.9
1.9
mg/l
2.7
2.8
0.13
154
1074
(3026493) Urate [Moles/volume] in Serum or Plasma
192
1382
1.49
5.42
2.2
1.9
umol/l
2572.7
4913.6
0.45
185
1245
(3030467) Casts [#/volume] in Urine by Automated count
196
1420
1.48
5.35
2.7
2.4
e6/l
0.3
0.4
0.53
159
972
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
18
5.61
5.33
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
220
1633
1.46
5.30
2.8
1.9
u/l
55.1
58.4
0.80
214
1513
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
19
522
0.35
5.30
3.6
3.2
%
28.2
33.1
1.02
13
373
(3010813) Leukocytes [#/volume] in Blood
894
8592
2.61
5.28
16.4
12.1
e9/l
6.4
6.5
0.98
889
8349
(3026361) Erythrocytes [#/volume] in Blood
894
8592
2.61
5.28
16.4
12.1
e12/l
4.5
4.5
0.14
887
8363
(3017143) Hepatitis C virus Ab [Presence] in Serum
132
880
1.58
5.28
1.7
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
893
8580
2.56
5.24
16.4
12.1
e9/l
269.0
264.0
1.27
888
8353
(3021960) Folate [Moles/volume] in Serum or Plasma
142
967
1.55
5.18
1.4
1.4
nmol/l
23.7
21.4
0.78
134
851
(40768797) Stomach Pathology biopsy report
108
689
1.64
5.17
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
50
252
2.04
5.13
1.6
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
128
856
1.58
5.05
2.4
2.4
ng/l
1185.1
794.7
0.34
115
702
(3027944) Amphetamines [Presence] in Urine
67
378
1.83
4.95
4.4
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
29
118
2.51
4.91
1.3
1.1
—
—
—
0
0
(4094501)
35
156
2.29
4.88
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
67
380
1.82
4.87
4.4
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
157
1108
1.50
4.85
4.7
3.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
68
390
1.80
4.77
3.0
2.3
%
1.7
1.7
0.01
62
346
(3026008) Bacteria identified in Urine by Culture
211
1583
1.43
4.76
2.4
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
51
268
1.96
4.68
3.6
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
66
379
1.80
4.62
4.4
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
173
1257
1.46
4.61
2.7
3.4
mg/mmol
7.4
7.2
0.02
138
728
(3000764) Benzodiazepines [Presence] in Urine
65
374
1.79
4.52
4.5
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
8
10.07
4.52
2.3
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
26
105
2.52
4.49
2.3
2.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
102
668
1.59
4.40
2.0
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
207
1568
1.41
4.39
2.7
2.4
e6/l
16.9
73.9
1.37
164
1099
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
49
261
1.93
4.34
1.4
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
221
1698
1.40
4.32
2.3
1.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
6
11.74
4.28
1.6
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
777
7251
1.47
4.22
3.4
3.4
mmol/l
4.9
5.0
1.94
743
6903
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
92
595
1.61
4.19
2.1
1.9
%
23.5
24.6
0.28
82
516
(3002032) Base excess in Venous blood by calculation
57
324
1.81
4.15
7.1
2.9
mmol/l
2.5
1.6
1.00
46
265
(3001122) Ferritin [Mass/volume] in Serum or Plasma
394
3327
1.32
4.13
2.6
2.4
ug/l
86.7
85.4
0.06
380
3162
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
39
195
2.04
4.13
9.1
3.0
mmol/l
24.1
23.9
0.17
33
177
(36304419) Bacteria [Presence] in Urine
192
1450
1.41
4.13
2.8
2.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
66
393
1.73
4.11
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
34
162
2.14
4.08
1.9
1.6
g/l
0.2
0.2
0.01
34
155
(3044640) Blood type and Crossmatch panel - Blood
145
1961
0.69
4.05
2.9
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
59
342
1.78
4.03
4.8
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
369
0.34
3.93
1.6
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
119
2.31
3.90
1.8
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
35
172
2.08
3.89
1.9
1.5
g/l
1.1
1.2
0.89
35
163
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
73
456
1.65
3.83
2.1
1.8
g/l
0.2
0.2
0.29
65
430
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
34
3.56
3.77
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
34
3.56
3.77
1.2
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
13
39
3.37
3.77
3.3
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
264
0.33
3.61
1.3
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
267
2171
1.32
3.55
4.2
3.6
g/l
36.5
36.8
0.44
255
2021
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
105
2.32
3.55
1.3
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
742
6927
1.37
3.49
3.2
3.1
mmol/l
1.3
1.2
0.85
723
6543
(40761536) Microorganisms panel - Urine sediment
37
661
0.54
3.40
3.2
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
172
1320
1.37
3.33
2.0
1.5
mg/l
1.3
0.9
0.65
130
993
(3012095) Magnesium [Moles/volume] in Serum or Plasma
104
730
1.48
3.30
4.1
3.0
mmol/l
0.8
0.8
0.12
98
696
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
7
8.62
3.26
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
7
8.62
3.26
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
7
8.62
3.26
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
7
8.62
3.26
1.0
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
8
234
0.34
3.21
2.1
1.8
e6/l
0.4
0.3
—
8
223
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
15
5.37
3.19
1.6
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
152
2.01
3.13
3.3
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
50
2.83
3.09
2.1
1.7
%
68.3
60.7
—
7
29
(3023520) Reticulocytes [#/volume] in Blood
43
248
1.77
3.05
2.2
2.4
e9/l
72.8
68.9
0.32
26
168
(3028192) IgG subclass 2 [Mass/volume] in Serum
13
45
2.92
3.03
1.2
1.4
g/l
2.8
2.8
0.04
13
24
(3027135) IgG subclass 1 [Mass/volume] in Serum
13
45
2.92
3.03
1.2
1.4
g/l
6.2
7.4
0.36
13
24
(3024139) IgG subclass 3 [Mass/volume] in Serum
13
45
2.92
3.03
1.2
1.4
g/l
0.4
0.4
0.09
13
24
(3007853) Bacteria identified in Skin by Aerobe culture
82
560
1.51
2.99
1.6
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
484
4322
1.25
2.91
3.6
3.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
242
1990
1.29
2.89
3.0
2.8
e6/l
161.5
92.2
0.64
171
1227
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
65
426
1.57
2.86
1.8
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
437
1.55
2.78
1.8
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
31
3.25
2.78
2.0
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
775
7352
1.35
2.75
3.5
3.6
mmol/l
2.9
3.0
0.73
741
6945
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
102
743
1.42
2.69
2.1
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
63
417
1.55
2.67
1.6
1.2
u/ml
144.8
165.6
0.16
58
384
(3036489) Thrombin time
36
206
1.78
2.65
3.7
1.8
s
19.4
20.8
1.55
31
177
(3019225) pH of Specimen
18
368
0.48
2.56
2.9
3.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
35
201
1.77
2.55
1.4
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
5
7
7.18
2.55
1.4
1.0
%
22.4
24.6
—
5
7
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
7
7.18
2.55
1.8
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
122
1.99
2.52
1.5
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
52
334
1.59
2.52
1.9
1.8
mu/l
386.4
306.5
0.38
42
293
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
761
7226
1.31
2.48
3.3
3.3
mmol/l
1.6
1.6
0.23
741
6849
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
145
1.89
2.44
1.6
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
34
2.96
2.42
3.4
2.1
—
—
—
0
0
(4062490)
12
46
2.63
2.36
1.2
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
289
0.44
2.34
1.7
1.7
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
9
28
3.24
2.31
2.4
1.4
—
9.4
—
0
8
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
78
558
1.43
2.30
1.8
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
228
1921
1.25
2.18
3.1
3.2
mmol/l
2.4
2.4
0.19
219
1772
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
24
3.35
2.18
3.5
3.8
nmol/l
66.3
127.4
—
8
24
(3007164) IgA [Mass/volume] in Serum or Plasma
172
1402
1.28
2.17
1.4
1.3
g/l
2.2
2.1
0.20
121
918
(4034850)
14
293
0.47
2.16
6.5
5.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
201
1672
1.26
2.15
1.3
1.2
u/ml
1.4
1.7
0.24
98
484
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
52
751
0.67
2.06
1.3
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
113
1435
0.76
2.05
2.7
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
44
2.52
2.01
1.2
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
80
1063
0.73
1.98
1.4
1.6
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
21
3.35
1.96
1.0
1.0
%
111.0
101.5
—
7
21
(3000991) Gas panel - Venous blood
48
323
1.51
1.95
9.5
6.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
11
4.56
1.94
1.4
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
11
4.56
1.94
3.4
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
113
1.88
1.93
1.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
763
7305
1.26
1.92
12.0
8.0
mg/l
16.7
20.9
3.25
616
5331
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
85
2.02
1.91
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
316
0.53
1.88
2.1
2.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
28
2.87
1.86
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
115
1.85
1.84
2.5
2.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
12
4.18
1.82
6.6
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
123
1.81
1.81
2.3
3.0
g/l
0.2
0.2
0.03
12
54
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
35
2.59
1.80
1.9
1.7
ug/l
37.6
21.3
—
9
35
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
167
0.41
1.80
1.4
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
208
1771
1.23
1.79
5.1
5.2
inr
1.1
1.1
0.42
135
620
(3011397) Hemoglobin [Presence] in Urine by Test strip
103
1299
0.77
1.78
2.3
2.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
373
0.58
1.78
2.1
2.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
17
88
1.95
1.75
1.6
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
17
88
1.95
1.75
1.6
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
178
1495
1.24
1.75
3.6
3.4
ph
7.4
7.4
0.56
70
346
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
7
24
2.93
1.72
1.0
1.0
g/l
0.3
0.3
—
7
19
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
96
1.89
1.71
1.4
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
46
0.00
1.71
0.0
1.9
—
14.0
—
0
18
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
68
2.08
1.71
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
97
1.87
1.67
1.6
1.5
e6/l
13443.8
15670.1
0.09
12
67
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
19
3.17
1.66
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
112
1.80
1.65
3.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
14
3.58
1.61
1.2
1.2
—
—
—
0
0
(44790048)
10
43
2.34
1.60
1.6
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
10
43
2.34
1.60
29.0
10.5
nmol/l
823.3
858.0
—
10
43
(44790047)
10
43
2.34
1.60
1.6
1.3
—
—
—
0
0
(44806118)
10
43
2.34
1.60
1.6
1.3
—
—
—
0
0
(44790049)
10
43
2.34
1.60
1.6
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
58
423
1.40
1.60
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
26
2.70
1.58
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
50
2.21
1.57
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
51
2.17
1.51
1.0
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
5
125
0.40
1.50
3.6
2.6
kpa
8.4
8.7
—
5
125
(3013290) Carbon dioxide [Partial pressure] in Blood
5
125
0.40
1.50
3.6
2.6
kpa
4.7
4.9
—
5
125
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
50
680
0.72
1.47
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
180
1.57
1.44
1.4
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
170
1458
1.20
1.37
1.8
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
23
2.62
1.37
2.8
3.2
ug/l
7.2
1.2
—
6
23
(3019060) Gas panel - Arterial blood
31
208
1.51
1.34
4.2
4.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
16
90
1.79
1.33
2.6
3.7
ratio
1.1
1.1
—
6
10
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
61
1.98
1.33
1.7
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
41
0.00
1.31
0.0
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
80
635
1.28
1.30
2.0
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
18
2.79
1.28
1.2
1.2
nmol/l
110.2
115.7
—
5
18
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
33
227
1.47
1.28
1.3
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
186
1.52
1.27
2.1
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
55
2.01
1.27
3.6
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
98
800
1.25
1.27
2.3
2.2
ug/g
117.8
118.7
0.01
75
635
(3000494) Fungus identified in Specimen by Culture
80
640
1.27
1.23
1.4
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
14
78
1.81
1.21
1.2
1.5
g/l
0.5
0.7
0.35
14
53
(3017732) Neutrophils [#/volume] in Blood
30
429
0.69
1.21
1.5
1.9
e9/l
5.8
4.0
0.44
25
374
(21494434) Karyotype in Bone marrow
6
26
2.32
1.19
1.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
51
386
1.34
1.17
5.2
6.1
mmol/l
1.2
0.8
0.29
43
298
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
11
58
1.91
1.12
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
14
81
1.74
1.09
2.9
2.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
21
2.39
1.09
1.0
1.9
%
148.4
106.6
—
5
21
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
287
1.37
1.08
2.7
3.2
%
19.7
20.7
—
10
98
(3050129) First trimester maternal screen panel - Serum or Plasma
30
418
0.71
1.07
1.2
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
110
1294
0.83
1.06
1.3
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
19
121
1.58
1.06
1.4
2.5
umol/l
3.8
5.3
1.14
12
94
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
220
1.42
1.06
1.4
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
90
1.68
1.04
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
98
1.64
1.03
1.6
1.2
u/ml
228.5
213.6
0.12
11
62
(3037522) Nuclear Ab [Titer] in Serum
101
849
1.21
1.03
1.3
1.3
titre
539.1
514.5
0.03
23
183
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
34
2.07
1.03
1.1
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
47
1.92
1.02
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
222
1.41
1.01
1.7
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
103
1212
0.83
1.01
4.1
3.0
kg/l
1.0
1.0
0.09
12
165
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
9
49
1.84
0.98
1.2
1.1
u/l
55.2
68.8
—
9
33
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
30
0.00
0.97
0.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
216
1.40
0.96
2.0
2.2
ug/l
0.7
0.7
0.04
12
103
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
13
77
1.70
0.95
1.9
4.3
u/ml
929.8
415.1
0.22
13
72
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
208
0.62
0.92
2.8
2.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
55
1.83
0.92
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
12
71
1.70
0.89
1.5
3.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
56
1.79
0.88
1.2
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
43
1.87
0.87
2.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
43
1.87
0.87
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
43
1.87
0.87
3.8
2.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
29
212
1.38
0.87
6.0
7.2
%
0.6
0.7
0.34
29
212
(3001019) Free T4 and TSH panel - Serum or Plasma
87
735
1.20
0.87
2.1
1.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
8
44
1.83
0.86
1.0
1.2
—
551.8
—
0
11
(3022217) INR in Platelet poor plasma by Coagulation assay
26
355
0.72
0.86
8.2
14.5
inr
1.4
1.1
—
10
47
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
104
1.55
0.85
1.5
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
46
1.75
0.82
1.4
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
40
311
1.30
0.82
5.8
6.7
g/l
120.2
122.5
0.29
40
300
(3026389) Candida sp identified in Specimen by Organism specific culture
12
73
1.65
0.82
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
89
1.58
0.81
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
494
5169
0.90
0.81
2.9
2.4
u/l
41.2
36.6
0.99
480
4952
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.78
0.0
1.0
—
53.3
—
0
26
(3014007) Fractional oxyhemoglobin in Arterial blood
29
217
1.35
0.77
6.1
7.1
%
93.0
94.1
0.40
29
217
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
59
1.70
0.76
1.2
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
169
1526
1.13
0.74
13.2
5.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
55
1.64
0.73
1.1
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
25
2.01
0.72
2.4
2.7
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
25
2.01
0.72
1.2
2.0
e9/l
0.2
0.7
—
5
25
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
25
2.01
0.72
2.8
4.7
u/ml
1203.6
893.9
—
5
25
(3044941) Cell count panel - Synovial fluid
12
76
1.59
0.72
1.6
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
105
920
1.16
0.71
2.4
2.7
mmol/l
2.5
2.4
0.61
96
807
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
204
1.33
0.69
1.3
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
28
213
1.32
0.69
6.3
7.1
%
2.0
1.4
1.29
28
213
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
669
0.83
0.68
1.2
1.2
iu/ml
66.8
176.7
4.45
19
272
(1761482) Bacteria [#/volume] in Urine by Culture
5
92
0.54
0.67
5.4
2.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
233
2160
1.11
0.65
5.7
4.4
mmol/l
1.2
1.2
0.13
225
1976
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
10
62
1.62
0.65
3.1
2.3
—
941.8
—
0
6
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
43
350
1.24
0.65
1.4
1.3
miu/ml
148.2
237.6
1.29
24
189
(3045414) Leukocytes [Presence] in Urine
16
224
0.71
0.64
1.3
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
10
154
0.65
0.64
2.0
2.9
u/ml
13.1
133.8
—
10
129
(3051651) Icteric interference index of Serum or Plasma
5
29
1.73
0.64
19.0
2.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
198
2142
0.90
0.61
3.6
2.5
u/l
31.5
30.8
0.10
191
2048
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
19
139
1.37
0.60
5.7
4.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
19
139
1.37
0.60
3.7
2.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
173
1881
0.90
0.59
7.6
5.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
18
131
1.38
0.59
1.8
1.6
—
173.3
—
0
6
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
463
0.81
0.58
5.1
4.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
53
1.51
0.58
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
53
1.51
0.58
1.1
2.2
pg
28.9
31.4
—
8
53
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
150
0.66
0.58
3.1
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
7
112
0.62
0.58
2.6
2.0
ug/l
0.6
1.9
—
7
97
(3043238) Trisomy 21 risk [Likelihood] in Fetus
39
319
1.23
0.58
1.4
1.5
—
—
—
0
0
(4010399)
27
341
0.79
0.57
1.4
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
26
203
1.29
0.56
3.2
2.5
g/l
130.3
129.9
0.04
26
198
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
201
1865
1.10
0.56
1.7
1.6
pmol/l
98.6
98.7
0.01
103
940
(40768793) Breast Pathology biopsy report
29
230
1.27
0.56
1.5
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
618
6011
1.09
0.56
3.6
3.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
37
1.63
0.55
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
249
1.25
0.54
2.2
2.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
91
1.43
0.53
1.2
1.2
u/ml
1.6
1.4
—
5
27
(3019309) Folate [Moles/volume] in Red Blood Cells
77
678
1.15
0.52
1.6
1.7
nmol/l
1509.1
1232.6
1.69
62
524
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
135
0.66
0.52
3.3
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
40
1.50
0.51
1.2
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
154
0.71
0.47
3.3
3.3
%
53.4
56.8
0.77
11
154
(4306422)
12
85
1.42
0.47
1.4
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
37
311
1.20
0.45
1.4
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
210
2231
0.92
0.45
1.5
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
50
1.40
0.45
9.3
7.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
50
1.40
0.45
1.4
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
295
2813
1.07
0.43
2.0
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
159
1706
0.92
0.43
1.5
1.5
mmol/l
1.5
1.3
1.43
152
1431
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
78
1.42
0.43
1.5
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
78
1.42
0.43
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
56
1.43
0.42
5.9
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
49
426
1.16
0.42
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.2
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
59
1.36
0.41
2.5
2.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
16
205
0.78
0.40
1.0
1.1
u/ml
2.9
5.6
—
5
45
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
18
0.00
0.40
0.0
3.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
215
0.79
0.39
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
36
308
1.18
0.38
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
52
587
0.88
0.37
2.8
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
200
0.80
0.34
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
73
1.37
0.34
1.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
155
1.23
0.32
6.2
2.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
10
74
1.36
0.32
1.3
1.2
pmol/l
221.7
299.8
—
10
56
(3011985) Renin [Units/volume] in Plasma
10
74
1.36
0.32
1.2
1.4
mu/l
18.5
31.7
—
10
66
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
84
912
0.91
0.32
1.4
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
55
1.27
0.30
1.6
1.4
—
—
—
0
0
(4268621)
7
55
1.27
0.30
2.6
2.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
106
0.75
0.29
5.4
4.9
mmol/l
1.2
1.2
—
8
96
(3014051) Protein [Presence] in Urine by Test strip
8
109
0.73
0.29
1.1
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
350
3396
1.05
0.28
1.8
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
195
1.18
0.28
1.9
2.1
iu/l
4.0
5.0
0.24
11
86
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
85
1.30
0.28
1.3
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
148
1559
0.94
0.27
5.1
2.8
%
96.8
98.2
0.38
141
1526
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
139
0.79
0.27
1.4
2.4
mg/l
10.9
9.3
0.66
11
131
(3002256) Pathology report gross observation
86
923
0.92
0.26
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
86
1.28
0.26
1.1
1.0
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
5
71
0.70
0.26
5.4
5.8
mmol/l
103.0
105.3
—
5
66
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
75
0.66
0.26
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
87
1.27
0.24
1.8
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
254
0.86
0.23
1.2
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
38
1.32
0.23
1.2
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
39
1.28
0.23
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
39
1.28
0.23
1.2
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
95
0.73
0.22
5.7
3.1
mmol/l
24.5
24.4
—
7
90
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
184
1769
1.05
0.22
1.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
79
1.27
0.22
4.7
2.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
3.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
108
1.21
0.20
1.4
1.3
ug/g
318.8
308.8
—
6
62
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
111
0.81
0.20
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
176
0.85
0.20
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
176
0.85
0.20
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
21
184
1.14
0.19
1.7
1.6
iu/ml
0.0
0.2
—
5
36
(3034770) Mitochondria Ab [Titer] in Serum
19
166
1.15
0.18
1.2
1.2
—
959.0
—
0
10
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
45
416
1.09
0.18
1.7
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
52
484
1.08
0.17
1.6
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
5
70
0.71
0.16
5.4
5.9
mmol/l
12.4
11.3
—
5
65
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
31
339
0.91
0.16
1.4
1.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
77
0.78
0.15
1.5
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
79
0.76
0.15
1.2
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
83
1.09
0.14
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
72
685
1.06
0.14
1.5
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
109
1049
1.04
0.14
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
100
0.80
0.13
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
108
0.83
0.13
4.0
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
74
773
0.95
0.12
2.5
2.3
e6/l
4.9
5.1
0.04
33
343
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
35
375
0.93
0.12
1.3
1.7
mg/l
2.3
4.5
0.75
24
254
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
11
126
0.87
0.11
1.0
1.1
u/ml
1.9
3.8
—
5
80
(3049717) Cytology report of Urine Cyto stain
12
105
1.14
0.11
2.4
2.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
662
1.05
0.11
3.6
2.0
umol/l
5.3
6.7
0.80
58
566
(1002224) Polysomnography panel
33
352
0.94
0.10
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
45
473
0.95
0.10
3.4
4.1
ug/l
21.0
7.8
0.41
37
352
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
166
0.90
0.10
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
45
1.11
0.10
1.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
46
1.09
0.09
19.0
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
31
291
1.07
0.09
1.1
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
24
223
1.08
0.09
1.7
2.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
55
1.09
0.09
2.0
1.4
—
—
—
0
0
(44813793)
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
76
785
0.97
0.08
3.1
2.5
ng/l
1864.3
503.4
0.46
37
485
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
60
0.83
0.08
1.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
62
0.81
0.08
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
184
1809
1.02
0.08
1.8
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
98
1.12
0.07
1.8
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
75
0.80
0.07
2.0
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
87
1.03
0.07
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
89
1.12
0.07
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
183
0.93
0.06
1.1
1.1
—
—
—
0
0
(4035726)
54
558
0.97
0.06
1.6
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
182
0.93
0.05
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
19
179
1.06
0.05
1.8
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
181
0.94
0.05
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
27
282
0.96
0.04
1.0
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
55
537
1.03
0.04
2.0
2.0
u/l
27.7
42.9
1.92
42
456
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
171
1.05
0.03
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
58
569
1.02
0.03
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
35
359
0.97
0.02
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
37
362
1.02
0.01
1.4
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
36
368
0.98
0.01
2.1
1.8
u/l
14311.8
5989.2
0.32
15
146
(3015736) pH of Urine
238
2390
0.99
0.01
3.1
2.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
21
217
0.97
0.01
1.2
2.2
u/l
39.5
39.5
0.00
21
200
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
237
0.97
0.01
2.2
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
80
808
0.99
0.01
2.4
2.2
e6/l
1.2
2.0
0.40
40
379
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
104
0.96
0.00
1.6
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
40
404
0.99
0.00
2.3
2.2
ml/min/173m2
79.4
76.3
0.18
16
159
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
49
486
1.01
0.00
3.2
2.9
u/ml
43.4
45.3
0.03
49
469
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
22
218
1.01
0.00
3.9
2.5
mmol/l
0.2
1.8
0.61
15
154
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
39
388
1.01
0.00
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
36
359
1.00
0.00
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
36
361
1.00
0.00
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
99
1.01
0.00
1.6
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
15
151
0.99
0.00
1.3
1.2
u/ml
4.1
10.2
—
7
22
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
141
0.99
0.00
1.3
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
19
185
1.03
0.00
5.8
7.1
mmol/l
23.7
24.2
0.21
19
175
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
59
0.85
0.00
2.2
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
2.2
—
0
5
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
56
0.89
0.00
1.0
1.3
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.2
—
1.9
—
0
6
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
15.0
—
0
6
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
70.7
—
0
9
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
5.4
—
274.0
—
0
5
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
3.0
—
1.0
—
0
6
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.9
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
69
1.01
0.00
2.0
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
114
1140
1.00
0.00
1.3
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
73
0.96
0.00
1.3
1.3
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
15.1
—
0
7
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
69
1.01
0.00
1.6
1.7
%
69.0
62.1
—
7
69
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
1.5
—
0
7
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
170
1.00
0.00
6.4
7.3
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
8
0.00
0.00
0.0
3.0
—
14.4
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_ROUTI_GENERAL_HEALTH_CHECK_DEFIN_SUBPO – Routine general health check-up of defined subpopulation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).